GC
ATRC icon

Guggenheim Capital’s AtriCure ATRC Stock Holding History

Guggenheim Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,875
Closed -$466K – 2127
2021
Q2 		$466K Sell
5,875
-1,072
-15% -$77.9K ﹤0.01% 1857
2021
Q1 		$455K Sell
6,947
-104
-1% -$6.41K ﹤0.01% 1761
2020
Q4 		$393K Sell
7,051
-133
-2% -$5.75K ﹤0.01% 1737
2020
Q3 		$287K Sell
7,184
-201
-3% -$8.52K ﹤0.01% 1652
2020
Q2 		$332K Sell
7,385
-201
-3% -$8.75K ﹤0.01% 1573
2020
Q1 		$255K Buy
7,586
+14
+0.2% +$503 ﹤0.01% 1588
2019
Q4 		$246K Buy
+7,572
New +$215K ﹤0.01% 1912
2014
Q3 		– Sell
-12,899
Closed -$237K – 2999
2014
Q2 		$237K Sell
12,899
-1,148
-8% -$19.1K ﹤0.01% 2844
2014
Q1 		$264K Buy
+14,047
New +$288K ﹤0.01% 2788

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Guggenheim Capital's ATRC Position: Q3 2021 in Review

Guggenheim Capital sold out of AtriCure (ATRC) in Q3 2021, closing a stake of 5,875 shares — an estimated $466K sold.

Guggenheim Capital first reported a position in ATRC in Q1 2014 and held it in 9 quarters. The position peaked at $466K in Q2 2021. 213 funds tracked by Wall St. Rank hold ATRC as of Q3 2021.

  • Guggenheim Capital reported no remaining AtriCure position as of Q3 2021 after selling out during the quarter.
  • Guggenheim Capital sold 5,875 AtriCure shares in Q3 2021, an estimated $466K.
  • Guggenheim Capital first reported a position in AtriCure in Q1 2014 and held it in 9 quarters.
  • Guggenheim Capital's AtriCure position peaked at $466K in Q2 2021.
  • 213 funds tracked by Wall St. Rank held AtriCure as of Q3 2021.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.